These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25253487)

  • 1. Tumour seeding as a result of intraperitoneal perforation during transurethral resection of non-muscle invasive bladder cancer.
    Cusano A; Murphy G; Haddock P; Wagner J
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25253487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed spontaneous perforation of urinary bladder with intraperitoneal seeding following radical transurethral resection of invasive urothelial cancer: a case report.
    Kim JH; Yang WJ
    BMC Res Notes; 2014 Mar; 7():167. PubMed ID: 24650321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial carcinoma in both adnexa following perforation during transurethral resection of a non-muscle-invasive bladder tumor: a case report and literature review.
    Bus MT; Cordeiro ER; Anastasiadis A; Klioueva NM; de la Rosette JJ; de Reijke TM
    Expert Rev Anticancer Ther; 2012 Dec; 12(12):1529-36. PubMed ID: 23253219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A; Chrisofos M; Ferakis N; Papatsoris A; Dellis A; Deliveliotis C
    J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer.
    Comploj E; Dechet CB; Mian M; Trenti E; Palermo S; Lodde M; Mian C; Ambrosini-Spaltro A; Horninger W; Pycha A
    World J Urol; 2014 Oct; 32(5):1219-23. PubMed ID: 24166290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
    Hassan O; Murati Amador B; Lombardo KA; Salles D; Cuello F; Marwaha AS; Daniels MJ; Kates M; Bivalacqua TJ; Matoso A
    World J Urol; 2020 Feb; 38(2):389-395. PubMed ID: 31030230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy.
    Wiesner C; Pfitzenmaier J; Faldum A; Gillitzer R; Melchior SW; Thüroff JW
    BJU Int; 2005 Feb; 95(3):301-5. PubMed ID: 15679782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder perforation as a complication of transurethral resection of bladder tumors: the predictors, management, and its impact in a series of 1570 at a tertiary urology institute.
    Osman Y; Elawdy M; Taha DE; Zahran MH; Abouelkheir RT; Sharaf DE; Mosbah A; Ali-El Dein B
    Int Urol Nephrol; 2023 Sep; 55(9):2161-2167. PubMed ID: 37318699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature.
    Mydlo JH; Weinstein R; Shah S; Solliday M; Macchia RJ
    J Urol; 1999 Apr; 161(4):1128-32. PubMed ID: 10081853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial.
    Gakis G; Karl A; Bertz S; Burger M; Fritsche HM; Hartmann A; Jokisch F; Kempkensteffen C; Miller K; Mundhenk J; Schneevoigt BS; Schubert T; Schwentner C; Wullich B; Stenzl A
    BJU Int; 2020 Oct; 126(4):509-519. PubMed ID: 32578332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intestinal obstruction and peritoneal carcinomatosis after endoscopic resection of transitional carcinoma of urinary bladder].
    Acea Nebril B; Aguirrezabalaga González J; Fraguela Mariña F; Taboada Filgueira L; Freire Rodríguez D; Gómez Freijoso C
    Actas Urol Esp; 1997; 21(7):705-7. PubMed ID: 9412216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.
    Chen GF; Shi TP; Wang BJ; Wang XY; Zang Q
    J Biol Regul Homeost Agents; 2015; 29(2):465-70. PubMed ID: 26122238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens.
    Paner GP; Brown JG; Lapetino S; Nese N; Gupta R; Shen SS; Hansel DE; Amin MB
    Am J Surg Pathol; 2010 Jun; 34(6):792-9. PubMed ID: 20421781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
    Brant A; Kates M; Chappidi MR; Patel HD; Sopko NA; Netto GJ; Baras AS; Hahn NM; Pierorazio PM; Bivalacqua TJ
    Urol Oncol; 2017 Jan; 35(1):34.e17-34.e25. PubMed ID: 27639777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients.
    Rehme C; Fritsch B; Thomas L; Istin S; Burchert C; Hummel B; Baleanu-Curaj B; Reis H; Szarvas T; Ruebben H; Hadaschik B; Niedworok C
    Int Urol Nephrol; 2022 Jan; 54(1):71-79. PubMed ID: 34817753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
    Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
    Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer.
    Mitra AP; Skinner EC; Miranda G; Daneshmand S
    BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.